Jazz Pharmaceuticals plc (JAZZ): 1 insider purchase in the last two years; 4 trades disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| May 13, 2025 | Mulligan Seamus Director | 101,621 | $98.33 | $10.0M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Aug 13, 2023 | Daniel Goldman | sale | $15,001 - $50,000 |
| Apr 17, 2023 | Daniel Goldman | purchase | $15,001 - $50,000 |
| Feb 24, 2023 | Daniel Goldman | sale | $1,001 - $15,000 |
| Nov 5, 2021 | Thomas Suozzi | purchase | $1,001 - $15,000 c |